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The beneficial effects of n-3 polyunsaturated fatty 
acids (PUFAs), primarily eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA), were 
first recognized in the late 1960s with epidemio-
logical evidence of the Inuit population, who 
consumed an n-3 PUFA-rich diet, having a low 
incidence of myocardial infarction (Mozaffarian 
and Wu, 2011). Subsequently, large-scale random-
ized clinical trials confirmed that dietary supple-
mentation of n-3 PUFAs prevented cardiovascular 
events in patients with recent myocardial infarc-
tion (Yokoyama et al., 2007), reduced mortality 
in patients with symptomatic chronic heart failure   
who were receiving standard treatment (Tavazzi 
et al., 2008), and ameliorated left ventricular (LV) 
functional capacity and decreased the circulating 
concentrations of inflammatory cytokines such as 
TNF, IL-1, and IL-6 in nonischemic dilated car-
diomyopathy (Nodari et al., 2011).
Increased cardiac afterload caused by hyper-
tension, aortic valve stenosis, or natural aging is 
responsible for the pathogenesis and progres-
sion of heart failure accompanied by common 
histological changes, the so-called maladaptive 
cardiac remodeling (Opie et al., 2006). Sustained 
pressure overload elicits cardiomyocyte hyper-
trophy, inflammatory cell infiltration, and fibrosis, 
thereby changing LV stiffness and geometry (Wynn 
and Ramalingam, 2012; Weber et al., 2013). The 
n-3  PUFAs  have  potential  anti-inflammatory 
activity in a variety of inflammatory diseases, in-
cluding atherosclerosis, diabetes, asthma and ar-
thritis (Fritsche, 2006; Zhang and Spite, 2012). 
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N-3 polyunsaturated fatty acids (PUFAs) have potential cardiovascular benefit, although 
the mechanisms underlying this effect remain poorly understood. Fat-1 transgenic mice 
expressing Caenorhabditis elegans n-3 fatty acid desaturase, which is capable of producing 
n-3 PUFAs from n-6 PUFAs, exhibited resistance to pressure overload–induced inflamma-
tion and fibrosis, as well as reduced cardiac function. Lipidomic analysis revealed selective 
enrichment of eicosapentaenoic acid (EPA) in fat-1 transgenic bone marrow (BM) cells and 
EPA-metabolite 18-hydroxyeicosapentaenoic acid (18-HEPE) in fat-1 transgenic macro-
phages. BM transplantation experiments revealed that fat-1 transgenic BM cells, but not 
fat-1 transgenic cardiac cells, contributed to the antiremodeling effect and that the 18-
HEPE–rich milieu in the fat-1 transgenic heart was generated by BM-derived cells, most 
likely macrophages. 18-HEPE inhibited macrophage-mediated proinflammatory activation 
of cardiac fibroblasts in culture, and in vivo administration of 18-HEPE reproduced the 
fat-1 mice phenotype, including resistance to pressure overload–induced maladaptive  
cardiac remodeling.
© 2014 Endo et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e1674 Macrophage-derived 18-HEPE prevents cardiac fibrosis | Endo et al.
activation upon pressure overload than WT mice, leading to 
preservation of %FS.
Myofibroblast activation by pressure overload in turn in-
duces the production of inflammatory cytokines and chemo-
kines (Koyanagi et al., 2000; Kuwahara et al., 2004; Ma et al., 
2012). Accordingly, the increased expression of Ccl2, Ccl3, 
Ccl5, Il6, and Cx3cl1 after TAC in this study was blunted in 
fat-1 mice compared with WT mice (Fig. 2 A).
Flow cytometric analysis of the temporal dynamics in the 
number and distribution of inflammatory cells revealed a grad-
ual increase in leukocyte numbers in the heart after TAC that 
remained elevated for at least 60 d. The majority (76.4 ± 7.6%) 
of leukocytes at 4 wk after TAC were CD11b+ F4/80+ macro-
phages (Fig. 2 B). However, the hearts of fat-1 mice showed 
fewer CD11b+ F4/80+ macrophages at 4 wk after TAC than 
those of WT mice (Fig. 2 C). Consistent with this, immuno-
staining demonstrated lower numbers of Mac2-positive mac-
rophages in the fibrotic areas of TAC-operated fat-1 mice 
compared with TAC-operated WT mice (Fig. 2 D).
BM-derived cells, but not cardiac cells, are crucial  
for cardioprotection under pressure overload
To address which cells are responsible for the antifibrotic fat-1 
phenotype, we prepared four chimeric mice by BM transplan-
tation (BMT): WT mice transplanted with WT BM (WT → 
WT), WT mice transplanted with fat-1 transgenic BM (fat-1 → 
WT), fat-1 mice transplanted with WT BM (WT → fat-1), 
and fat-1 mice transplanted with fat-1 transgenic BM (fat-1 → 
fat-1). We then subjected these BMT chimera mice to pres-
sure overload by TAC.
The  pressure  overload–induced  reduction  in  %FS  was 
comparable between WT → WT and WT → fat-1 chimera 
mice, whereas %FS was preserved in fat-1 → WT chimera mice 
to the same levels as in fat-1 → fat-1 chimera mice (Fig. 3 A). 
There was less cardiac fibrosis and fewer myocardial macro-
phages in the fat-1 → WT and fat-1 → fat-1 chimera mice 
compared with the WT → WT and WT → fat-1 chimera 
mice (Fig. 3 B). However, cardiomyocyte hypertrophy induced 
by the pressure overload was similar among the four BMT 
chimera mice (Fig. 3 C). Consistent with this, the pressure 
overload–induced up-regulation of Nppa, Col1a1, Tgfb1, Cx3cl1, 
and Emr1 was also less in the fat-1 → WT and fat-1 → fat-1 chi-
mera mice compared with the other two chimeras (Fig. 3 D).
To visualize BM-derived cells, we prepared three additional 
mouse chimeras: WT mice transplanted with GFP transgenic 
mice BM (WT/GFP → WT), WT mice transplanted with 
fat-1/GFP double-transgenic mice BM (fat-1/GFP → WT), 
and fat-1 mice transplanted with GFP transgenic mice BM 
(WT/GFP → fat-1). The reconstitution of BM cells among 
these three chimeras showed equivalently high efficiency (WT/
GFP → WT; 92.98 ± 0.44%, fat-1/GFP → WT; 92.30 ± 
1.36%, WT/GFP → fat-1; 92.00 ± 1.03%). Histological analy-
sis of hearts revealed equal numbers of BM-derived GFP+ 
cells in WT/GFP → WT and fat-1/GFP → WT mice before 
the TAC operation. BM-derived GFP+ cells increased in the 
hearts of all mice at 4 wk after TAC; however, BM-derived 
Thus, beneficial antiremodeling effects of n-3 PUFAs in the 
setting of chronic heart failure can be explained by the anti-
inflammatory activity, although the mechanisms underlying 
such effects are poorly understood.
Mammals  cannot  naturally  produce  n-3  fatty  acids,  so 
they must rely on a dietary supply. Recently, Kang et al. (2004) 
developed a transgenic mouse expressing the C. elegans fat-1 
gene encoding n-3 desaturase, which converts n-6 to n-3 
PUFAs. These fat-1 mice show enrichment of n-3 PUFAs in 
almost all organs and tissues, and display a resistant phenotype 
against inflammatory diseases including colitis (Hudert et al., 
2006), pancreatitis (Weylandt et al., 2008), osteoarthritis 
(Huang et al., 2012), atherosclerosis (Wan et al., 2010), obe-
sity-linked insulin resistance (White et al., 2010), and some 
kinds of cancer (Xia et al., 2006; Weylandt et al., 2011).
In this study, we investigated the effect of expressing the 
C. elegans fat-1 transgene on pressure overload–induced car-
diac remodeling. The results demonstrated that fat-1 mice are 
protected from cardiac remodeling in this model, and that this 
effect is conferred by BM-derived cells. We further demon-
strated that 18-HEPE, which was found at higher levels in 
macrophages from fat-1 mice, inhibits proinflammatory acti-
vation of cardiac fibroblasts and that in vivo administration of 
18-HEPE reproduces the fat-1 phenotype on pressure overload–
induced cardiac remodeling.
RESULTS
Preserved LV function and less fibrosis  
in fat-1 mice under pressure overload
To examine the impact of elevated tissue n-3 PUFA levels in 
the setting of maladaptive cardiac remodeling, we subjected 
both fat-1 transgenic mice and WT mice to pressure overload 
by transverse aortic constriction (TAC). The pressure overload–
induced  increase  in  the  heart  weight  (HW)/body  weight 
(BW) ratio was reduced in fat-1 mice compared with WT 
mice at 4 wk after TAC (Fig. 1 A). Echocardiographic analysis 
of cardiac function revealed that the pressure overload– 
induced decline in percentage fractional shortening (%FS) 
observed in the WT mice was also significantly alleviated in 
fat-1 mice at 4 wk after TAC (Fig. 1 B), as was the increase in 
Nppa and Nppb expressions (Fig. 1 C), whereas measurement 
of the cardiomyocyte surface area demonstrated similar levels 
of cardiomyocyte hypertrophy between fat-1 mice and WT 
mice after TAC (Fig. 1 D). Pressure overload–induced perivas-
cular and interstitial fibrosis were also less in fat-1 mice compared 
with WT mice (Fig. 1 E). TAC induces the differentiation of 
cardiac fibroblasts into myofibroblasts, as characterized by the ex-
pression of -smooth muscle actin (-SMA). In this study, im-
munohistochemical analysis revealed fewer -SMA–positive cells   
in the fibrotic area apparent in TAC-operated fat-1 transgenic 
hearts compared with that area in the TAC-operated WT 
hearts (Fig. 1 F), and consistent with this, the pressure overload–
induced increase in the expressions of Col1a1, Col3a1, and 
Tgfb1 was less in fat-1 mice compared with WT mice (Fig. 1 G). 
These findings indicated that fat-1 mice showed less fibroblast JEM Vol. 211, No. 8 
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cell types. The proportion of n-3 PUFAs (EPA [C20:5, n-3], 
DPA [C22:5, n-3], DHA [C22:6, n-3]) per total lipid was ex-
tremely low in BM cells (1% of total lipid), whereas the 
proportion of DHA per total lipid was markedly high in heart 
cells. The proportion of DHA was increased in the fat-1 trans-
genic heart cells (25% of total lipid) compared with WT 
heart cells (10% of total lipid), whereas the proportion of ara-
chidonic acid (AA) was reduced in the fat-1 transgenic heart 
cells (7.5% of total lipid) compared with WT heart cells 
(15% of total lipid). Fatty acid composition was comparable 
GFP+ cells were significantly fewer in number in the fat-1/
GFP → WT mice compared with WT/GFP → WT mice 
(Fig. 3 E). Notably, the majority of GFP+ cells in the 4-wk 
post-TAC hearts were CD68+ macrophages (Fig. 3 F).
Fat-1 transgenic BM cells contained markedly higher 
proportions of EPA compared with WT BM cells
We measured the n-6 and n-3 PUFA compositions in heart 
cells and BM cells from the chimeras by GC-MS (Fig. 3 G) 
and found that fatty acid composition differed among different 
Figure 1.  Fat-1 mice showed preserved LV function and less cardiac fibrosis than WT mice after TAC. (A) Heart weight/body weight (HW/BW) 
ratios from WT and fat-1 transgenic hearts. n = 10. (B) %FS after TAC measured by echocardiography. n = 20. (C) Relative expression levels of Nppa and 
Nppb mRNA 4 wk after TAC. Expression levels were normalized to those of 18s ribosomal RNA and then normalized with respect to those in the WT 
sham-operated hearts. n = 10. (D) Myocardial cross-sectional area (CSA) measured by staining with WGA at the papillary muscle level in ventricle section 
4 wk after TAC. n = 450–500. (E, left) Representative low-magnification views of Azan staining of the heart sections 4 wk after TAC. Image is a compila-
tion of two independent experiments. Bar, 1 mm. (right) Measurement of the fibrotic area in a ventricle section. *, P < 0.05; **, P < 0.01. Data in E were 
analyzed by Kruskal-Wallis tests followed by Bonferroni post-hoc analysis. (F) Myofibroblast transformation evaluated in heart sections stained with  
anti–-SMA antibody. Bars, 100 µm. (G) Relative expression levels of cardiac fibrosis-associated genes (Col1a1, Col3a1, and Tgfb1). n.s. indicates not  
significant; *, P < 0.05; **, P < 0.01. Data in A−C and G were analyzed by Mann-Whitney U tests. Experiments were repeated three times and the data  
were pooled.1676 Macrophage-derived 18-HEPE prevents cardiac fibrosis | Endo et al.
Fat-1 transgenic macrophages were less potent  
in activating cardiac fibroblasts than WT macrophages
Next, we examined the distinct functions between WT mac-
rophages and fat-1 transgenic macrophages in cardiac fibroblast 
between the fat-1 transgenic BM cells and WT BM cells ex-
cept for EPA, which was increased markedly in the fat-1 trans-
genic BM cells (0.5% of total lipid) compared with WT 
BM cells (0.1% of total lipid).
Figure 2.  Fat-1 mice showed less macrophage infiltration in the heart after TAC than WT mice. (A) Relative expression levels of Ccl2, Ccl3, Ccl5, 
Il6, and Cx3cl1 mRNA in WT and fat-1 transgenic hearts 0, 1, and 4 wk after TAC. n = 5. *, P < 0.05; **, P < 0.01. Data were analyzed by Mann-Whitney  
U tests. (B) FACS analysis of myocardial inflammatory cells. Macrophages were identified as CD45+, CD11b+, or F4/80+, as shown in the dot images (left). 
The temporal change in number of inflammatory cells in TAC hearts (right). n = 8. (C) Concentration of CD45+ CD11b+ F4/80+ cells per heart weight in WT 
and fat-1 transgenic hearts 0, 2, and 4 wk after TAC measured by flow cytometry. n = 8. n.s. indicates not significant; *, P < 0.05; **, P < 0.01. Statistical 
analysis was performed using Kruskal-Wallis tests followed by Bonferroni post-hoc analysis. (D) Activated macrophages expressing Mac2 accumulated in 
the fibrotic tissue area. Azan staining (top) and immunohistochemistry for Mac2 (bottom) in ventricle sections from WT or fat-1 mice 4 wk after TAC. 
Bars, 100 µm. Experiments were repeated three times and the data pooled.JEM Vol. 211, No. 8 
Article
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Figure 3.  BM-derived cells elicited cardiac protection against pressure overload in fat-1 mice. (A) %FS of the prepared BMT chimeras subjected 
to TAC. n = 20. (B) Azan staining and immunohistochemistry for Mac2 in ventricle sections from the BMT chimera mice after TAC. Bars, 100 µm. (C) Myo-
cardial CSA in ventricle section of BMT chimera mice subjected to pressure overload for 4 wk. n = 5; n = 450–500. (D) Relative expression levels of Nppa, 
Col1a1, Tgfb1, Cx3cl1, and Emr1 in the hearts of BMT chimera mice 4 wk after TAC. Expression levels were normalized to those of 18S ribosomal RNA and 
then normalized with respect to those in the sham operated hearts. n = 6. (E) Immunofluorescence images for BM-derived GFP+ macrophages in ventricle 1678 Macrophage-derived 18-HEPE prevents cardiac fibrosis | Endo et al.
mRNAs (Fig. 4 C) and resultant IL-6 and MCP-1 proteins 
(Fig. 4 D), whereas fat-1 transgenic macrophage–conditioned 
media had a less potent effect. In contrast, cardiac fibroblast– 
conditioned media equally stimulated both WT macrophages 
and fat-1 transgenic macrophages to produce IL-6 and MCP-1, 
although the levels produced were 40- and 10-fold less, respec-
tively, than those produced by cardiac fibroblasts (Fig. 4 E). These 
in vitro studies indicated that fat-1 transgenic macrophages are 
less potent proinflammatory activators of cardiac fibroblasts, 
probably due to either reduced secretion of proinflammatory 
molecules or increased secretion of antiinflammatory molecules.
activation. Co-culturing cardiac fibroblasts with WT macro-
phages in a Transwell culture chamber system increased the ex-
pressions of Il6 and Ccl2 mRNAs, but this effect was significantly 
less potent when co-culturing cardiac fibroblasts with fat-1 trans-
genic macrophages (Fig. 4 A). Consistent with this, co-culturing 
cardiac fibroblasts with WT macrophages increased the IL-6 and 
MCP-1 protein concentrations in culture media, but this effect 
was significantly less potent when co-culturing cardiac fibroblasts 
with fat-1 transgenic macrophages (Fig. 4 B). Similarly, stimula-
tion of cardiac fibroblasts with WT macrophage-conditioned 
media up-regulated the expression of Il6, Ccl2, and Col3a1 
sections of sham- or TAC-operated heart from the chimeras transplanted with WT or fat-1/GFP double-transgenic BM. Bars, 100 µm. (F) The majority of 
GFP-positive cells in the sham or TAC-operated hearts from WT mice transplanted with the GFP transgenic BM expressed CD68, a macrophage marker 
(cyan). Bars, 50 µm. (G) The fatty acid composition of hearts and BM cells from the four BMT chimeras. n = 5. N.D. indicates not detected. n.s. indicates 
not significant; *, P < 0.05; **, P < 0.01 versus WT → WT BMT chimera group. Statistical analysis was performed using Kruskal-Wallis tests followed by 
Bonferroni post-hoc analysis. Experiments were repeated three times and the data pooled.
 
Figure 4.  Fat-1 transgenic macrophages exerted anti-inflammatory effects when co-cultured with cardiac fibroblasts. (A) Relative expression 
levels of Il6 and Ccl2 mRNA in cardiac fibroblasts cultured with WT or fat-1 transgenic macrophages using a Transwell system for 48 h. n = 5. Expression 
levels were normalized to those of 18S ribosomal RNA and then normalized with respect to those in the vehicle sample. (B) Concentrations of IL-6 and 
MCP-1 in the culture medium of cardiac fibroblasts cultured with WT or fat-1 transgenic macrophages using a Transwell system and ELISA. n = 5.  
(C) Relative expression levels of Il6, Ccl2, and col3a1 mRNA in cardiac fibroblasts stimulated with WT or fat-1 transgenic macrophage-conditioned 
medium for 48 h. n = 5. (D) Concentrations of IL-6 and MCP-1 in the culture medium of cardiac fibroblasts stimulated with WT or fat-1 transgenic  
macrophage-conditioned medium for 48 h. n = 5. (E) Concentrations of IL-6 and MCP-1 in the medium of WT or fat-1 transgenic macrophages stimu-
lated with WT cardiac fibroblast-conditioned medium. n.s. indicates not significant; *, P < 0.05; **, P < 0.01. Statistical analysis was performed using  
Kruskal-Wallis tests followed by Bonferroni post-hoc analysis. Experiments were repeated twice.JEM Vol. 211, No. 8 
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media. Cardiac fibroblasts were stimulated with WT macrophage- 
conditioned media either in the presence or absence of lipid 
extracts  (Fig.  6 A).  Notably,  the  lipid  extracts  from WT   
macrophage-conditioned media did not further increase IL-6 
production by cardiac fibroblasts, whereas the lipid extracts from 
fat-1 transgenic macrophage-conditioned media significantly 
suppressed IL-6 production by cardiac fibroblasts.
Next, we performed LC-MS/MS-based lipidomic analysis 
of AA and EPA metabolites released into the WT macrophage- 
and fat-1 transgenic macrophage-conditioned media (Fig. 6 B). 
Among EPA metabolites, the levels of 12-HEPE, 15-HEPE, 
and 18-HEPE were higher in fat-1 transgenic macrophage-
conditioned  media  than  in WT  macrophage-conditioned   
media. Among AA metabolites, the levels of TXB2 and PGE2 
were  increased,  whereas  12-HETE  was  decreased  in  fat-1 
transgenic macrophage-conditioned media compared with WT 
macrophage-conditioned media. Then, we stimulated cardiac 
An EPA-derived metabolite, 18-HEPE,  
suppressed cardiac fibroblast activation
To examine the impact of EPA enrichment on gene expression 
in macrophages, we compared the gene expression profiles be-
tween WT and fat-1 transgenic macrophages. The expression 
of inflammation-related genes in macrophages isolated from 
post-TAC hearts was comparable between WT and fat-1 mice 
(Fig. 5 A), as was the expression of M1 or M2 marker genes 
(Fig. 5, B and C). Also, there was no difference in the expression 
levels of inflammatory genes (Ccl2, Ccl3, Ccl5, and Il6) in cir-
culating monocytes between WT and fat-1 mice under pres-
sure overload (Fig. 5 D). Therefore, we speculated that free fatty 
acid and the resulting metabolites released among macrophages 
are responsible for the distinct phenotypes observed in WT 
mice and fat-1 mice under the pressure-overload conditions.
To confirm this hypothesis, lipids were extracted from both 
WT macrophage and fat-1 transgenic macrophage-conditioned 
Figure 5.  The gene expression profiles of 
macrophages were comparable between 
WT and fat-1 mice. (A) Dot plot compari-
sons of gene expression profiles among macro-
phages isolated from sham or 2 wk after TAC 
hearts of WT or fat-1 mice. (B and C) The 
relative gene expression levels of (B) resident 
peritoneal macrophages or (C) LPS-stimulated 
(1 µg/ml for 4 h) peritoneal macrophages 
from WT or fat-1 mice. n = 5. (D) The relative 
gene expression levels of blood monocytes 
(CD11b+ Ly6C+ Ly6G) from WT and fat-1 
mice 3 d after TAC operation. n = 4. Expres-
sion levels were normalized to those of 18S 
ribosomal RNA and then normalized with 
respect to those in (B and C) WT resident peri-
toneal macrophage or (D) WT circulating 
monocytes. Data were analyzed by (B and D) 
Mann-Whitney U tests or (C) Kruskal-Wallis 
tests followed by Bonferroni post-hoc analy-
sis. Experiments were repeated twice and the 
data were pooled.1680 Macrophage-derived 18-HEPE prevents cardiac fibrosis | Endo et al.
Figure 6.  Mediator lipidomics identified 18-HEPE as a major EPA metabolite released by fat-1 transgenic macrophages. (A) Concentration of 
IL-6 in culture medium of the cardiac fibroblasts stimulated with macrophage-conditioned medium in the presence of fatty acid extracts from WT or fat-1 
transgenic macrophage-conditioned medium. n = 5. (B) LC-MS/MS-based lipidomic analysis of WT or fat-1 transgenic macrophage-conditioned 
medium. 18-HEPE was monitored by MRM mode using the established transition (317 > 259 m/z). n = 4. *, P < 0.05; **, P < 0.01. Data in B were analyzed 
by Mann-Whitney U tests. (C–E) Concentrations of IL-6 in the culture medium of cardiac fibroblasts stimulated with macrophage-conditioned medium in 
the presence of (C) 100 nM EPA, 5-, 12-, 15-, 18-HEPE; (D) RvE1, RvE2, RvE3, TXB2, 12-HETE, and PGE2; or (E) 10 and 100 nM 18-HEPE. n = 5. (F) Relative 
expression levels of Il6, Ccl2, and Tgfb1 mRNA of cardiac fibroblasts stimulated with macrophage-conditioned medium in the presence of 100 nM  
18-HEPE. n = 5. N.D. indicates not detected. n.s. indicates not significant; *, P < 0.05; **, P < 0.01. Data in A and C–F were analyzed by Kruskal-Wallis  
tests followed by Bonferroni post-hoc analysis. Experiments were repeated twice.JEM Vol. 211, No. 8 
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is usually given orally at 3–10 mg/day, prevented pressure 
overload–induced cardiac dysfunction (Duda et al., 2007; 
Chen et al., 2011).
Notably, 18-HEPE administered at a dose of 1 or 5 µg by 
intraperitoneal injection every 3 d from the beginning of 
pressure overload significantly mitigated the reduction in   
%FS (Fig. 8 A), as well as increases in perivascular and intersti-
tial fibrosis (Fig. 8 B), macrophage infiltration (Fig. 8 C), and 
expression of Nppa, Col1a1, Tgfb1, Cx3cl1, and Emr1 mRNA 
(Fig.  8  D),  without  affecting  cardiomyocyte  hypertrophy   
(Fig. 8 E) at 4 wk after TAC. The protective effect of 18-HEPE 
was compatible with the phenotype observed for fat-1 transgenic 
mice. Notably, the same dose of EPA had no effect on pres-
sure overload–induced cardiac fibrosis and inflammation.
To clarify whether a delayed application of 18-HEPE can 
also exert a therapeutic effect on maladaptive cardiac remod-
eling under pressure overload, we started the 18-HEPE ad-
ministration 1 wk after TAC surgery. A delayed application of 
18-HEPE was similarly effective (Fig. 8, F and G).
DISCUSSION
Using fat-1 transgenic mice carrying C. elegans n-3 fatty acid 
desaturase, which is capable of producing n-3 PUFAs from   
n-6 PUFAs, we demonstrated the potential mechanisms by 
which n-3 PUFA exhibits resistance to pressure overload– 
induced cardiac remodeling. Sustained communication between 
cardiac fibroblasts and BM-derived immune cells, especially 
macrophages, play a key role in the progression of cardiac fibro-
sis.  Activated  cardiac  fibroblasts  produce  proinflammatory   
cytokines and chemokines, such as IL-6 and MCP-1, facilitat-
ing macrophage activation (Koyanagi et al., 2000; Sano et al., 
2000; Kuwahara et al., 2004; Kayama et al., 2009; Meléndez 
et al., 2010; Ma et al., 2012). Cardiac fibroblasts can be acti-
vated directly by pressure overload or secondarily by inflam-
matory mediators released from activated inflammatory cells 
(Nicoletti et al., 1996; Koyanagi et al., 2000; Kuwahara et al., 
2004; Kai et al., 2006). This pro-fibrotic feed-forward loop 
accelerated the progression of cardiac fibrosis under pres-
sure overload. We demonstrated here that BM-derived and 
EPA-enriched fat-1 transgenic macrophages generated an 
18-HEPE-rich milieu in the heart, thereby counter-regulating 
the profibrotic feed-forward loop established under pressure-
overload conditions.
BMT studies indicated the importance of BM cells in the 
observed protective effects against cardiac remodeling. Pro-
tection conferred by the fat-1 transgenic BM cells was com-
parable between fat-1 → WT and fat-1 → fat-1 chimeric mice 
in this study, indicating that the fat-1 transgenic BM cells   
accounted for the full effect of the fat-1 transgene on cardiac 
remodeling, and the contribution of cardiomyocytes to adap-
tive changes in fat-1 mice was minor, if any. Using lipidomic 
analysis, we identified selective enrichment of EPA in fat-1 
transgenic BM cells and the EPA monooxygenated metabo-
lite, 18-HEPE, in fat-1 transgenic macrophages. Furthermore, 
the levels of EPA and 18-HEPE were selectively increased   
in fat-1 transgenic hearts compared with sham-operated WT 
fibroblasts with WT macrophage-conditioned media either in 
the presence or absence of 100 nM EPA, 5-HEPE, 12-HEPE, 
or 18-HEPE (Fig. 6 C). Among them, only 18-HEPE sup-
pressed IL-6 production from cardiac fibroblasts. Metabolites 
of 18-HEPE, namely RvE1, E2, and E3 had no effect on IL-6 
production from cardiac fibroblasts. Among metabolites of AA, 
TXB2 and 12-HETE had no effect on IL-6 production from 
cardiac fibroblasts, whereas 100 nM PGE2 increased pro-
duction (Fig. 6 D). We observed dose-dependent suppres-
sion of IL-6 production from cardiac fibroblasts exposed to 
18-HEPE, with 10 nM a sufficient concentration to elicit 
this effect (Fig. 6 E). The increased expression of Il-6, Ccl2, 
and Tgfb1 mRNA in cardiac fibroblasts with WT macrophage-
conditioned media was also significantly attenuated by 18-
HEPE (Fig. 6 F).
BM-derived cells generated an 18-HEPE–rich  
milieu in fat-1 transgenic heart
LC-MS/MS-based lipidomic analyses of lipid mediators re-
vealed that the levels of EPA and its monooxygenated prod-
uct 18-HEPE were selectively elevated in sham-operated 
fat-1 transgenic hearts compared with sham-operated WT 
hearts (Fig. 7, A and B), and these levels remained elevated 
in the fat-1 transgenic hearts at 4 wk after TAC. In contrast, 
AA and its metabolites in sham-operated hearts were com-
parable between WT and fat-1 transgenic mice. The levels 
of AA metabolites PGE2 and 12-HETE, prostanoids known 
to be involved in cardiac fibrosis and inflammation, were 
comparable between WT and fat-1 transgenic mice at 4 wk 
after TAC.
Finally, the BMT study revealed that levels of both EPA 
and 18-HEPE were appreciably high in the hearts of fat-1 → 
WT and fat-1 → fat-1 chimera compared with WT → WT 
and WT → fat-1 chimera (Fig. 6 C). These findings indicated 
that 18-HEPE in fat-1 transgenic hearts were mostly derived 
from BM cells.
Plasma 18-HEPE concentrations increased  
after oral administration of EPA in humans
We next asked whether dietary intake of EPA could increase 
plasma levels of 18-HEPE in humans. LC-MS/MS was used 
to measures a series of fatty acid metabolites in fasting plasma 
from healthy volunteers who took oral doses of high-purity 
EPA ethyl ester (2,700 mg/day Epadel) for 14 d (Table 1). 
Dietary intake of EPA significantly increased the plasma con-
centration of 18-HEPE compared with controls not fed with 
EPA (95.6 ± 23.7 pg/ml vs. 149.0 ± 12.7 pg/ml; P = 0.000721; 
Table 1). The plasma concentration of other EPA metabolites, 
including RvE2 and RvE3, were not significantly increased 
under this condition.
Administration of 18-HEPE prevented pressure  
overload–induced cardiac fibrosis and inflammation
Lastly, we examine the therapeutic effect of 18-HEPE on mal-
adaptive cardiac remodeling under pressure overload. Previ-
ous studies demonstrated that administration of EPA, which   1682 Macrophage-derived 18-HEPE prevents cardiac fibrosis | Endo et al.
very low in WT → WT and WT → fat-1 chimera. Collectively, 
these results indicated that 18-HEPE in fat-1 transgenic hearts 
mostly derived from BM cells.
hearts. The BMT study also demonstrated that both EPA   
and 18-HEPE levels in the hearts were appreciably high in 
fat-1 → WT and fat-1 → fat-1 chimera, whereas levels were 
Figure 7.  18-HEPE enriched in fat-1 transgenic heart was mainly produced by the BM-derived cells. (A) LC-MS/MS-based lipidomic analysis of 
the hearts from WT or fat-1 mice. n = 4. Data were analyzed by Mann-Whitney U tests. (B) The level of AA, EPA, 18-HEPE, PGE2, and 12-HETE production 
of pre- or post-TAC hearts from WT or fat-1 mice measured by LC-MS/MS. n = 4. (C) The level of EPA and 18-HEPE production of hearts from the four BMT 
chimeras. n = 4. Data in (B and C) were analyzed by Kruskal-Wallis tests followed by Bonferroni post-hoc analysis. Experiments were repeated twice. N.D. 
indicates not detected. n.s. indicates not significant; *, P < 0.05; **, P < 0.01.JEM Vol. 211, No. 8 
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Flow cytometric analysis in this study identified macro-
phages as the major type of leukocytes in all heart tissues. It 
also showed that macrophage numbers in heart gradually in-
creased after TAC and remained elevated for at least 60 d. 
Consistent with this, BMT studies using WT/GFP transgenic 
mice and fat-1/GFP double-transgenic BM revealed equal 
numbers of BM-derived GFP+ cells in the hearts of WT/ 
GFP → WT and fat-1/GFP → WT mice before TAC surgery, 
and an increased number under pressure overload. Notably, 
the majority of GFP+ cells in the hearts were CD68+ macro-
phages. Together, these results indicated that the 18-HEPE–rich   
milieu in the fat-1 transgenic heart was generated by BM- 
derived macrophages.
Blood monocytes are recruited to heart in the early phase 
of left ventricular pressure overload. Ly-6Chigh monocytes   
selectively express CCR2, a receptor for MCP-1, whereas   
Ly-6Clow monocytes express high levels of CX3CR1, a recep-
tor for Fractalkine (Nahrendorf et al., 2007; Epelman et al., 
2014). We also found herein that pressure-overloaded hearts 
modulate their chemokine expression profile over time. Ccl2  
(MCP-1) mRNA levels peaked at 1 wk after TAC, whereas 
Cx3cl1 (Fractalkine) mRNA levels peaked at 4 wk after TAC. 
These findings suggested a biphasic response of monocytes to 
myocardial mechanical injury. Because both Ccl2 (MCP-1) 
Table 1.  Profile of lipid mediators in human plasma of healthy volunteers taking dietary EPA at 2.7 g/day
EPA-derived lipid mediator EPA 0w (pg/ml) EPA 2w (pg/ml) P value
PGE3 26.4 ± 5.9 32.0 ± 13.2 0.699428347
PGD3 7.2 ± 2.7 9.9 ± 3.4 0.506270699
PGF3 90.3 ± 33.8 80.5 ± 44.2 0.825358514
6-keto-PGF1a-17delta 72.4 ± 48.4 80.6 ± 71.4 0.772022261
TXB3 10.8 ± 3.6 16.6 ± 6.8 0.243550461
LTB5 7.6 ± 1.6 10.9 ± 1.5 0.301981898
LXA5 3.2 ± 1.5 15.2 ± 5.7 0.526795284
RvE2 10.1 ± 4.1 24.9 ± 13.5 0.397489159
RvE3 55.3 ± 8.5 42.3 ± 13.8 0.349509121
5-HEPE 309.7 ± 84.2 270.1 ± 51.8 0.756489821
8-HEPE 48.7 ± 13.3 88.9 ± 25.7 0.060813559
9-HEPE 55.0 ± 18.1 95.3 ± 17.9 0.151960325
8,9-EpETE 29.6 ± 10.0 68.7 ± 37.7 0.341822254
11-HEPE 36.3 ± 9.1 44.0 ± 8.9 0.471267817
12-HEPE 58.8 ± 17.5 72.2 ± 12.8 0.351678213
11,12-EpETE 109.9 ± 27.2 257.5 ± 138.6 0.335749115
15-HEPE 149.3 ± 24.4 188.2 ± 36.0 0.346843422
14,15-EpETE 46.8 ± 14.6 131.5 ± 86.8 0.416135401
18-HEPE 95.6 ± 23.7 149.0 ± 12.7 0.000720547
17,18-EpETE 144.8 ± 46.3 220.3 ± 98.1 0.463858736
17,18-diHETE 3855.4 ± 371.3 7364.9 ± 928.5 0.002201551
19-HEPE 584.5 ± 126.9 1205.3 ± 195.8 0.038534813
20-HEPE 189.3 ± 62.5 266.4 ± 30.3 0.153533361
5,15-diHEPE 9.9 ± 3.4 20.2 ± 7.3 0.372063162
8,15-diHEPE 37.7 ± 5.6 32.7 ± 9.5 0.618181239
8,18-diHEPE 6.8 ± 3.3 15.3 ± 4.9 0.068913138
12,18-diHEPE 11.1 ± 4.9 24.7 ± 5.6 0.068628042
mRNA levels and Cx3cl1 (Fractalkine) mRNA levels were 
suppressed in fat-1 transgenic hearts, we speculate that the se-
quential recruitment of monocyte subsets was attenuated in 
fat-1 transgenic hearts. However, it remains unknown what 
proportion of monocytes differentiated into macrophages after 
being recruited to the pressure-overloaded hearts, although 
reported turnover rates of monocytes in injured heart are <24 h 
(Leuschner et al., 2012). Our experimental results indicated 
that the majority of 18-HEPE was generated by preexisting 
macrophages and hence focused on the communication be-
tween cardiac fibroblasts and macrophages in terms of the 
profibrotic feed-forward loop accelerating the progression of 
cardiac fibrosis under pressure overload in this study. Future 
studies are necessary to elucidate the relative contribution of 
other fat-1 transgenic immune cells to cardiac fibrosis under 
pressure overload, including different monocyte subsets.
We stimulated cardiac fibroblasts with WT macrophage-
conditioned media either in the presence or absence of 100 nM 
of EPA, 18-HEPE, RvE1, RvE2, and RvE3. Among them, only 
18-HEPE blunted IL-6 production from cardiac fibroblasts, 
whereas RvE1, RvE2, and RvE3 at the same concentration 
had no such effect. In humans, dietary intake of high-purity 
EPA ethyl ester (2,700 mg/day Epadel) significantly increased 
the plasma concentration of 18-HEPE compared with controls 1684 Macrophage-derived 18-HEPE prevents cardiac fibrosis | Endo et al.
increased after oral administration of EPA. In mice, previous 
studies demonstrated that EPA alleviates pressure overload–
induced cardiac dysfunction when given orally at 3–10 mg/day 
not fed with EPA (95.6 ± 23.7 pg/ml vs. 149.0 ± 12.7 pg/ml; 
P = 0.000721). The plasma concentrations of other EPA me-
tabolites including RvE2 and RvE3 were not significantly 
Figure 8.  18-HEPE administration elicited cardioprotection in TAC-operated mice. (A) %FS of post-TAC mice administered with NS, 5 µg EPA,  
1 µg or 5 µg 18-HEPE i.p. every 3 d. n = 12–20. (B) Azan staining and (C) immunohistochemistry for Mac2 in ventricle sections of the mice administered 
with 18-HEPE after TAC. Bars, 100 µm. (D) Relative expression levels of Nppa, Col1a1, Tgfb1, and Emr1 mRNA in hearts from mice administered with  
18-HEPE 4 wk after TAC. Expression levels were normalized to those of 18S ribosomal RNA, and then normalized with respect to those in the sham-operated 
hearts. n = 7. (E) Myocardial CSA in ventricle section of pressure-overloaded heart from the mice administered with NS, 5 µg EPA or 5 µg 18-HEPE. n = 5; 
n = 450–500. (F and G) 18-HEPE administration at 1 wk after TAC induction could prevent cardiac remodeling. (F) %FS of the mice administered with  
18-HEPE at 5 µg every 2 d from 1 wk after TAC. n = 16. (G) Azan staining and immunohistochemistry for Mac2 in ventricle sections from the mice adminis-
tered with 18-HEPE from 1 wk after TAC induction. Bars, 100 µm. n.s. indicates not significant; *, P < 0.05; **, P < 0.01 vs. N/S control group. Data in A, B, 
D, and F were analyzed by Kruskal-Wallis tests followed by Bonferroni post-hoc analysis. Experiments were repeated three times and the data pooled.JEM Vol. 211, No. 8 
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Echocardiography and hemodynamic measurements. Mice were 
anesthetized by 1.5% isoflurane inhalation, and then anchored to a position-
ing platform in the supine position. Short-axis echocardiographic and Dopp-
ler echocardiographic measurements were made using the Vevo 660 system 
(Visual Sonics) with a 600 series real-time microvisualization scanhead probe. 
The LV internal end-systolic and end-diastolic diameters (LVESD and LVEDD, 
respectively) were measured using the leading-edge convention adopted by 
the American Society of Echocardiography. LV fractional shortening (FS) was 
calculated according to the formula: FS (%) = ([LVEDD – LVESD]/LVEDD) × 
100. Heart rate did not differ significantly among the groups during the 
echocardiographic assessments.
Histological analysis and immunostaining. Mice were anesthetized and 
sacrificed. Hearts were then immediately perfused with PBS, fixed with 10% 
formalin neutral buffer solution, and embedded in paraffin. After deparaf-
finization, the sections were incubated in 0.3% H2O2 for 15 min and blocked 
in 5% BSA for 30 min at room temperature. Next, the sections were incu-
bated with anti–Mac-2 antibody (clone M3/38; eBioscience; 1:200) or anti–
-smooth muscle actin antibody (-SMA, clone 1A4; Sigma-Aldrich; 1:200) 
overnight at 4°C. Secondary antibodies conjugated with HRP were applied 
for 1 h at 4°C. Antibody binding was detected by incubating the sections in 
DAB substrate for 10 min at room temperature.
To evaluate the fibrotic area, short-axis sections at the mid LV level were 
stained with Azan and analyzed quantitatively against control reference sec-
tions using BZ-II Analyzer software (Keyence) on a BIOREVO BZ-9000 
microscope (Keyence). The number of pixels with the predetermined level of 
blue tone were counted in each section, and then automatically converted 
into dimensions.
For immunofluorescence staining, the sections were incubated with 
anti-CD68 antibody (clone FA-11; AbD Serotec) overnight at 4°C, and then 
in secondary antibodies conjugated with TRITC (Dako; 1:200) for 1 h at 
4°C. Nuclei were stained with Topro (Molecular Probes) in mounting me-
dium, and the slides were observed by confocal laser-scanning microscopy 
(LSM510; Carl Zeiss) using appropriate emission filters.
Isolation and culture of adult murine cardiac fibroblasts. Hearts were 
perfused and digested with collagenase II (Worthington Biochemical Corp). 
Dissociated cells were incubated with anti-CD45-conjugated microbeads 
(Miltenyi Biotec), followed by selective depletion of CD45+ cells using   
autoMACS (Miltenyi Biotec). The remaining CD45- cells were resuspended in 
DMEM (Life Technologies) containing 10% fetal bovine serum and placed on 
Primaria culture dishes (BD). After 2 h, the culture medium was changed to re-
move any myocytes and endothelial cells still weakly attached to the dish. After 
24 h, the culture medium was changed again, and the fibroblast cultures were 
grown to 85% confluence, at which point the medium was replaced with 
DMEM containing 0.1% FBS (serum-reduced medium). After a further 24 h, the 
isolated fibroblasts were cultured with co-cultured macrophages and macrophage-
conditioned medium with or without 18-HEPE (Cayman Chemical).
Co-culture of cardiac fibroblasts with macrophages. Macrophages 
were isolated from peritoneal lavage by using anti-CD11b microbeads (Mil-
tenyi Biotec) on autoMACS (Miltenyi Biotec). Adult murine cardiac fibro-
blasts (5 × 105 cells/well) were co-cultured with CD11b+ peritoneal macrophages 
(5 × 105 cells/well) on 24-well plates using Transwell inserts (Corning) with a 
0.4-µm porous membrane or with conditioned medium harvested from the 
24-h CD11b+ macrophage cultures. After incubation for 48 h, the superna-
tants and the cultured cells on the lower dish were harvested, and ELISA was 
used to determine IL-6 concentrations in the supernatants, according to the 
manufacturer’s instructions (R&D Systems).
RNA extraction and real-time PCR. Total RNA was extracted by acid 
guanidinium thiocyanate-phenol-chloroform extraction with ISOGEN re-
agent (Nippon Gene). Reverse transcription was performed using the Prime 
Script RT reagent kit (Takara) in accordance with the manufacturer’s proto-
col. Real-time PCR was performed using the SYBR Premix Ex Taq kit (Takara) 
(Duda et al., 2007; Chen et al., 2011). In this study, 18-HEPE 
administered at a dose of 5 µg by intraperitoneal injection 
every 3 d was sufficient to achieve the same effect and plasma 
18-HEPE concentrations reached 30 pg/ml at 3 h after in-
jection. In culture, n-3 fatty acids at 100 µM reportedly stim-
ulate  GPR120  production  and  mediate  anti-inflammatory 
effects (Oh et al., 2010), whereas again here, we demonstrated 
a maximal such effect with 18-HEPE at 10 nM. Therefore, we 
strongly speculate that the physiological function of 18-HEPE 
is mediated through the high-affinity receptor.
Further work is needed to clarify the relationship be-
tween the fatty acid metabolome and cardiac pathology, with 
the ultimate goal to develop a novel therapeutic application 
for heart failure based on antiinflammatory and antifibrotic 
lipid mediators.
MATERIALS AND METHODS
Animals. Fat-1 mice (C57BL/6 background) were bred in the University of 
Tokyo animal facility. Fat-1 mice and the WT littermates were fed a special 
diet (AIN-76A; Oriental Yeast Co., Ltd) containing 9.4% safflower oil with a 
fatty acid composition of C18:1 n-9 (8–25%) and C18:2 n-6 (60–80%). WT 
littermates were always used as controls for the experiments involving fat-1 
mice. In the 18-HEPE administration study, WT C57BL/6 mice were pur-
chased at 5 wk of age from CLEA Japan Inc. and then fed the safflower oil–
containing special diet described above. After 2 wk passed, the mice were 
subjected to TAC operation and then subsequently fed the same special diet. 
The University of Tokyo Animal Committee approved all experimental pro-
cedures and protocols.
Blood  collection. This  study  evaluated  peripheral  blood  from  healthy 
human volunteers who took high-purity EPA ethyl ester 2.7 g/day for 14 d 
(protocol 20130089, approved by the Ethics Committee of Keio University, 
Tokyo, Japan; written informed consent was obtained from all donors). Fast-
ing venous blood (5 ml) was collected from each donor before and 2 wk after 
EPA administration. Plasma was separated by centrifugation, and then added 
to 2 ml methanol. Samples were stored at 20°C for 2 h to precipitate 
plasma proteins and preserved at 80°C until extraction. Upon extraction, 
precipitated plasma proteins were separated by centrifugation and the super-
natant was used for extraction.
Materials. EPA, 18-HEPE, RvE1, and other fatty acid metabolites were 
obtained from Cayman Chemical. RvE2 and RvE3 were chemically synthe-
sized as described previously (Ogawa et al., 2009; Isobe et al., 2013).
BM transplantation. BM cells were harvested from the femurs and tibias of 
8-wk-old recipient mice. After irradiation with a lethal dose of 10 Gy, the 
unfractionated BM cells (106 cells) were transferred intravenously into the ir-
radiated donor mice, which were then allowed to rest for 8 wk. Success of the 
BMT was confirmed by positive detection of the fat-1 transgene in periph-
eral blood cells from the recipient mice using PCR, and then flow cytometry 
to assess the frequency of GFP-positive cells among peripheral nucleated 
blood cells from the transgenic mice was used to determine chimeric rates 
after BMT.
Generation of LV hypertrophy by transverse aortic constriction. 
Mice were subjected to LV pressure overload by TAC as previously described 
(Endo et al., 2007). In brief, mice were ventilated with 2% isoflurane in room 
air. The chest cavity was then exposed by cutting open the second left inter-
costal space. After isolating the aortic arch between the innominate and left 
common carotid arteries, it was constricted with a 7–0 nylon suture tied 
firmly three times against a 27-gauge blunted needle. Control mice were 
subjected to sham operations, and all animals were studied at 2, 4, and 8 wk 
after surgery.1686 Macrophage-derived 18-HEPE prevents cardiac fibrosis | Endo et al.
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in an ABI Prism 7500 sequence detection system (Applied Biosystems). The 
obtained data were normalized against the expression levels of mouse 18S re-
combinant RNA.  The sequences of primer pairs were designed using Primer3 
plus and are described in Table S1.
FACS analysis. Hearts were perfused with PBS and digested with collage-
nase. The infiltrated leukocytes in the digested supernatants were blocked 
with anti-mouse CD16/32 antibody (2.4G2; BD) for 5 min and then stained 
with antibodies to either FITC-conjugated anti–mouse CD45 (30-F11; eBio-
science), PE-conjugated anti–mouse Gr-1 (RB6–8C5; BD), APC-conjugated 
anti–mouse F4/80 (BM8; eBioscience), or Pacific Blue–conjugated anti–mouse 
CD11b (M1/70; BioLegend) for 20 min. Cells were analyzed for composition 
using FACS Aria 2 (BD) with data analyzed by Flow Jo (Tree Star Inc.).
Measurements of fatty acids by GC-MS. Lipids were extracted by the 
method of Bligh and Dyer (Bligh and Dyer, 1959). Isolated phospholipids 
were methylated with 2.5% H2SO4 in methanol, and then the fatty acid 
methyl esters were extracted with hexane and subjected to gas chromatography-
mass spectrometry (GC-MS) analysis. GC-MS analysis was performed by 
using an Agilent 7890A-5975C GC-MS network system (Agilent Technolo-
gies) equipped with a DB-23 capillary column (60 m × 250 µm × 0.15 µm;   
Agilent Technologies). The oven temperature program was as follows: an ini-
tial temperature of 50°C held for 1 min was raised to 175°C at 25°C/min, 
and then to 235°C at 5°C/min, and held for 5 min. The injector and detector 
temperatures were both set at 250°C.
Mediator lipidomics. LC-MS/MS–based lipidomics analyses were performed 
using a high-performance liquid chromatography (HPLC) system (Waters 
UPLC) with a linear ion-trap quadrupole mass spectrometer (QTRAP5500; 
AB SCIEX) equipped with an Acquity UPLC BEH C18 column (Waters) as 
described previously (Arita, 2012). MS/MS analyses were conducted in neg-
ative-ion mode, and fatty acid metabolites were identified and quantified by 
multiple reaction monitoring (MRM).
Statistical analysis. Values are presented as mean ± SEM. Comparisons be-
tween groups were made using a Mann-Whitney U test, whereas data among 
multiple groups were compared using the Kruskal-Wallis test with Bonfer-
roni post-hoc testing. P < 0.05 was considered statistically significant. Statisti-
cal analysis was performed with SPSS 22.0 for Windows (SPSS, Inc.).
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